Document is current
Any future updates will be listed below
-
Authors
Cheruiyot, Collins K.
Kim, Sarah Y.
Dubrot, Juan https://orcid.org/0000-0002-8093-2208
Lane-Reticker, Sarah K.
Miranda, Alex
Kammula, Ashwin V. https://orcid.org/0000-0001-5284-721X
Perera, Jonathan J. https://orcid.org/0000-0003-3224-6075
Du, Peter P. https://orcid.org/0000-0003-2652-0541
Chuong, Cun Lan
Fetterman, Rachel A.
Knudsen, Nelson H. https://orcid.org/0000-0002-0384-1097
Jiang, Aiping https://orcid.org/0000-0002-8389-2950
Suermondt, Juliette S. M. T.
Pass, Lomax F.
Fu, Cong
Wu, Meng-Ju https://orcid.org/0000-0001-6847-7065
Shi, Lei https://orcid.org/0000-0003-1149-0474
Anderson, Seth https://orcid.org/0000-0003-2419-0585
Muscato, Audrey J. https://orcid.org/0000-0003-2009-6313
Avila, Omar I. https://orcid.org/0000-0002-3853-9939
Kohnle, Ian C.
Kessler, Emily A. https://orcid.org/0000-0002-2608-6020
Pope, Hans W.
Noel, Sarah G. https://orcid.org/0009-0006-9223-207X
Olander, Kira E. https://orcid.org/0000-0002-3356-7631
Chung, Jooho https://orcid.org/0000-0003-3625-0143
Colvin, Kayla J.
Bardeesy, Nabeel
Yates, Kathleen B. https://orcid.org/0000-0002-7383-5573
Manguso, Robert T. https://orcid.org/0000-0003-1336-413X
- License Information
-
More Information
Article History
Received: 27 July 2024
Accepted: 28 April 2026
First Online: 9 June 2026
Competing interests
: This work was supported by funding from Calico Life Sciences. R.T.M. and K.B.Y. receive research funding from Calico Life Sciences. N.B. has received a research grant from Servier Laboratories. R.T.M. has received speaking or consulting fees from Bristol Myers Squibb, Gilead Sciences, Kumquat Biosciences, Immunai Therapeutics and BioNTech, and has equity ownership in OncoRev. Calico Life Sciences and the Broad Institute participated in data interpretation and in the review and approval of the paper. The remaining authors declare no competing interests.
